Quarterly report pursuant to Section 13 or 15(d)

Restatement of Financial Statements (Details) - Schedule of statement of stockholder???s deficit

v3.21.1
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2020
As Filed [Member]    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning $ 6,179,466 $ 6,925,612
Conversion of Series A Convertible Preferred Stock into common stock
Settlement of Accounts Payable 847,200 2,605,390
Shares issued in cashless exercise of warrants
Shares issued in cashless exercise of options
Warrants exercised for cash   38,570
Shares issued to current and former employees and directors 142,225 142,225
Stock based compensation 488,304 2,844,851
Net Loss (4,085,516) (8,984,969)
Balance at ending $ 3,571,679 $ 3,571,679
As Filed [Member] | Preferred Stock    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning (in Shares) 94,872 578,567
Balance at beginning $ 95 $ 579
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (5,000) (488,695)
Conversion of Series A Convertible Preferred Stock into common stock $ (5) $ (489)
Settlement of Accounts Payable  
Shares issued in cashless exercise of warrants  
Shares issued in cashless exercise of options
Warrants exercised for cash  
Shares issued to current and former employees and directors  
Stock based compensation  
Net Loss  
Balance at ending (in Shares) 89,872 89,872
Balance at ending $ 90 $ 90
As Filed [Member] | Common stock    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning (in Shares) 9,490,582 7,390,261
Balance at beginning $ 9,491 $ 7,391
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) 13,158 1,286,042
Conversion of Series A Convertible Preferred Stock into common stock $ 13 $ 1,286
Settlement of Accounts Payable (in Shares) 157,000 441,567
Settlement of Accounts Payable $ 157 $ 442
Shares issued in cashless exercise of warrants (in Shares) 68,715 415,904
Shares issued in cashless exercise of warrants $ 69 $ 416
Shares issued in cashless exercise of options (in Shares) 28,890 86,424
Shares issued in cashless exercise of options $ 29 $ 86
Warrants exercised for cash (in Shares)   7,000
Warrants exercised for cash   $ 7
Shares issued to current and former employees and directors (in Shares) 87,255 218,402
Shares issued to current and former employees and directors $ 87 $ 218
Net Loss  
Balance at ending (in Shares) 9,845,600 9,845,600
Balance at ending $ 9,846 $ 9,846
As Filed [Member] | Additional paid-in capital    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning 23,863,806 19,712,115
Conversion of Series A Convertible Preferred Stock into common stock (8) (797)
Settlement of Accounts Payable 847,043 2,604,948
Shares issued in cashless exercise of warrants (69) (416)
Shares issued in cashless exercise of options (29) (86)
Warrants exercised for cash   38,563
Shares issued to current and former employees and directors 142,138 142,007
Stock based compensation 488,304 2,844,851
Net Loss  
Balance at ending 25,341,185 25,341,185
As Filed [Member] | Accumulated deficit    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning (17,693,926) (12,794,473)
Conversion of Series A Convertible Preferred Stock into common stock
Settlement of Accounts Payable
Shares issued in cashless exercise of warrants
Shares issued in cashless exercise of options
Warrants exercised for cash  
Shares issued to current and former employees and directors  
Stock based compensation  
Net Loss (4,085,516) (8,984,969)
Balance at ending (21,779,442) (21,779,442)
As Restated [Member]    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning 6,179,466 6,925,612
Conversion of Series A Convertible Preferred Stock into common stock  
Settlement of Accounts Payable 847,200 2,605,390
Shares issued in cashless exercise of warrants
Shares issued in cashless exercise of options  
Warrants exercised for cash   38,570
Shares issued to current and former employees and directors 142,225 142,225
Stock based compensation 488,304 2,844,851
Net Loss (2,747,213) (7,646,666)
Balance at ending $ 4,909,982 $ 4,909,982
As Restated [Member] | Preferred Stock    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning (in Shares) 94,872 578,567
Balance at beginning $ 95 $ 579
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (5,000) (488,695)
Conversion of Series A Convertible Preferred Stock into common stock $ (5) $ (489)
Settlement of Accounts Payable
Shares issued in cashless exercise of warrants
Shares issued in cashless exercise of options  
Warrants exercised for cash  
Shares issued to current and former employees and directors  
Stock based compensation
Net Loss  
Balance at ending (in Shares) 89,872 89,872
Balance at ending $ 90 $ 90
As Restated [Member] | Common stock    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning (in Shares) 9,490,582 7,390,261
Balance at beginning $ 9,491 $ 7,391
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) 13,158 1,286,042
Conversion of Series A Convertible Preferred Stock into common stock $ 13 $ 1,286
Settlement of Accounts Payable (in Shares) 157,000 441,567
Settlement of Accounts Payable $ 157 $ 442
Shares issued in cashless exercise of warrants (in Shares) 68,715 415,904
Shares issued in cashless exercise of warrants $ 69 $ 416
Shares issued in cashless exercise of options (in Shares) 28,890 86,424
Shares issued in cashless exercise of options $ 29 $ 86
Warrants exercised for cash (in Shares)   7,000
Warrants exercised for cash   $ 7
Shares issued to current and former employees and directors (in Shares) 87,255 218,402
Shares issued to current and former employees and directors $ 87 $ 218
Stock based compensation  
Net Loss  
Balance at ending (in Shares) 9,845,600 9,845,600
Balance at ending $ 9,846 $ 9,846
As Restated [Member] | Additional paid-in capital    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning 23,863,806 19,712,115
Conversion of Series A Convertible Preferred Stock into common stock (8) (797)
Settlement of Accounts Payable 847,043 2,604,948
Shares issued in cashless exercise of warrants (69) (416)
Shares issued in cashless exercise of options (29) (86)
Warrants exercised for cash   38,563
Shares issued to current and former employees and directors 142,138 142,007
Stock based compensation 488,304 2,844,851
Net Loss  
Balance at ending 25,341,185 25,341,185
As Restated [Member] | Accumulated deficit    
Restatement of Financial Statements (Details) - Schedule of statement of stockholder’s deficit [Line Items]    
Balance at beginning (17,693,926) (12,794,473)
Conversion of Series A Convertible Preferred Stock into common stock  
Settlement of Accounts Payable
Shares issued in cashless exercise of warrants
Shares issued in cashless exercise of options  
Warrants exercised for cash  
Shares issued to current and former employees and directors  
Stock based compensation
Net Loss (2,747,213) (7,646,666)
Balance at ending $ (20,441,139) $ (20,441,139)